Parathyroid and calcium metabolism disorders during pregnancy

Gynecological Endocrinology

Volumn 29, Issue 6, 2013, Pages 515-519

  Parkes, Ilana ^a   Schenker, Joseph G ^a   Shufaro, Yoel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Calcium metabolism; Hyperparathyroidism, hypoparathyroidism; Pregnancy

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CALCIUM ION; CINACALCET; MITHRAMYCIN; VITAMIN D;

ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; ELECTROLYTE DISTURBANCE; FETOPLACENTAL UNIT; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOALBUMINEMIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; INTESTINE ABSORPTION; OSTEOPOROSIS; PARATHYROID DISEASE; PARATHYROID GLAND; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SEIZURE; TETANY; VITAMIN D DEFICIENCY;

ANIMALS; BONE AND BONES; CALCIUM; CALCIUM METABOLISM DISORDERS; FEMALE; FETUS; HUMANS; OSTEOPOROSIS; PARATHYROID DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84877632498     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.754880     Document Type: Article

References (65)

1. Pitkin RM. Calcium metabolism in pregnancy and the perinatal period: A review. Am J Obstet Gynecol 1985;151:99-109
2. Gertner JM, Coustan DR, Kliger AS, et al. Pregnancy as state of physiologic absorptive hypercalciuria. Am J Med 1986;81:451-6
3. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984;74:1966-71
4. Seki K, Makimura N, Mitsui C, et al. Calcium-regulating hormones and osteocalcin levels during pregnancy: A longitudinal study. Am J Obstet Gynecol 1991;164:1248-52
5. Dahlman T, Sjoberg HE, Bucht E. Calcium homeostasis in normal pregnancy and puerperium: A longitudinal study. Acta Obstet Gynecol Scand 1994;73:393-8
6. Delvin EE, Arabian A, Glorieux FH, Mamer OA. In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. J Clin Endocrinol Metab 1985;60:880-5
7. Weisman Y, Harell A, Edelstein S, et al. 1 Alpha, 25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979;281:317-9
8. Kolthoff N, Eiken P, Kristensen B, Nielsen SP. Bone mineral changes during pregnancy and lactation: A longitudinal cohort study. Clin Sci (Lond) 1998;94:405-12
9. Cross NA, Hillman LS, Allen SH, et al. Calcium homeostasis and bone metabolism during pregnancy, lactation: Postweaning -A longitudinal study. Am J Clin Nutr 1995;61:514-23
10. Ardawi MS, Nasrat HA, Baaqueel HS. Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: A longitudinal study. Eur J Endocrinol 1997;137:402-9
11. Hacker AN, Fung EB, King JC. Role of calcium during pregnancy: Maternal and fetal needs. Nutrition Rev 2012;70:397-409
12. Ritchie LD, Fung EB, Halloran BP, et al. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Amer J Clin Nutrition 1998;67:693-701
13. Della Martina M, Biasioli A, Vascotto L, et al. Bone ultrasonometry measurements during pregnancy. Arch Gynecol Obstet 2010;281:401-7
14. Wisser J, Florio I, Neff M, et al. Changes in bone density and metabolism in pregnancy. Acta Obstet Gynecol Scand 2005;84:349-54
15. Schauberger CW, Pitkin RM. Maternal-perinatal calcium relationships. Obstet Gynecol 1979;53:74-6
16. Husain SM, Mughal MZ. Mineral transport across the placenta. Arch Dis Child 1992;67:874-8
17. Belkacemi L, Bedard I, Simoneau L, Lafond J. Calcium channels, transporters and exchangers in placenta: A review. Cell Calcium 2005;37:1-8
18. Hirota Y, Anai T, Miyakawa I. Parathyroid hormone-related protein levels in maternal and cord blood. Am J Obstet Gynecol 1997;177:702-6
19. Hellman P, Ridefelt P, Juhlin C, et al. Parathyroid-like regulation of parathyroid-hormone-related protein release and cytoplasmic calcium in cytotrophoblast cells of human placenta. Arch Biochem Biophys 1992;293:174-80
20. Bradbury RA, Sunn KL, Crossley M, et al. Expression of the parathyroid Ca(2)-sensing receptor in cytotrophoblasts from human term placenta. J Endocrinol 1998;156:425-30
21. Strid H, Care A, Jansson T, Powell T. Parathyroid hormone-related peptide (38-94) amide stimulates ATP-dependent calcium transport in the Basal plasma membrane of the human syncytiotrophoblast. J Endocrinol 2002;175:517-24
22. Miller BS, Dimick J, Wainess R, Burney RE. Age-And sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg 2008;32:795-9
23. Schnatz PF, Thaxton S. Parathyroidectomy in the third trimester of pregnancy. Obstet Gynecol Surv 2005;60:672-82
24. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:2036-40
25. Ficinski ML, Mestman JH. Primary hyperparathyroidism during pregnancy. Endocr Pract 1996;2:362-7
26. Bilezikian JP, Silverberg SJ. Clinical practice: Asymptomatic primary hyperparathyroidism. N Engl J Med 2004;350:1746-51
27. Carella MJ, Gossain VV. Hyperparathyroidism and pregnancy: Case report and review. J Gen Intern Med 1992;7:448-53
28. Schenker JG, Kallner B. Fatal postpartum hyperarathyroid crisis due to primary chief cell hyperplasia of parathyroids: Report of a case. Obstet Gynecol 1965;25:705-9
29. Molitch ME. Pituitary, thyroid, adrenal and parathyroid disorders. In: Barron LM, ed. Medical disorders during pregnancy. 3rd ed. St Louis: Mosby; 2000. pp. 101-146
30. Graham EM, Freedman LJ, Forouzan I. Intrauterine growth retardation in a woman with primary hyperparathyroidism: A case report. J Reprod Med 1998;43:451-4
31. Kort KC, Schiller HJ, Numann PJ. Hyperparathyroidism and pregnancy. Am J Surg 1999;177:66-8
32. Montoro MN, Collea JV, Mestman JH. Management of hyperparathyroidism in pregnancy with oral phosphate therapy. Obstet Gynecol 1980;55:431-4
33. Cooper MS. Disorders of calcium metabolism and parathyroid disease. Best Pract Res Clin Endocrinol Metab 2011;25:975-83
34. Shoback D. Clinical practice: Hypoparathyroidism. N Engl J Med 2008;359:391-403
35. Li Y, Song YH, Rais N, et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996;97:910-4
36. Alikasifoglu A, Gonc EN, Yalcin E, et al. Neonatal hyperparathyroidism due to maternal hypoparathyroidism and vitamin D deficiency: A cause of multiple bone fractures. Clin Pediatr (Phila) 2005;44:267-9
37. Loughead JL, Mughal Z, Mimouni F, et al. Spectrum and natural history of congenital hyperparathyroidism secondary to maternal hypocalcemia. Am J Perinatol 1990;7:350-5
38. Goldberg LD. Transmission of a vitamin-D metabolite in breast milk. Lancet. 1972;2:1258-9
39. Kaur M, Pearson D, Godber I, et al. Longitudinal changes in bone mineral density during normal pregnancy. Bone 2003;32:449-54
40. Naylor KE, Iqbal P, Fledelius C, et al. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 2000;15:129-37
41. Thomas M, Weisman SM. Calcium supplementation during pregnancy and lactation: Effects on the mother and the fetus. Am J Obstet Gynecol 2006;194:937-45
42. Feigenberg T, Ben-Shushan A, Daka K, et al. Ultrasound-diagnosed puerperal osteopenia in young primiparas. J Reprod Med 2008;53:287-93
43. Drinkwater BL, Chesnut 3rd CH. Bone density changes during pregnancy and lactation in active women: A longitudinal study. Bone Miner 1991;14:153-60
44. Kritz-Silverstein D, Barrett-Connor E, Hollenbach KA. Pregnancy and lactation as determinants of bone mineral density in postmenopausal women. Am J Epidemiol 1992;136:1052-9
45. Hellmeyer L, Kuhnert M, Ziller V, et al. The use of i. v. bisphosphonate in pregnancy-Associated osteoporosis-case study. Exp Clin Endocrinol Diabetes 2007;115:139-42
46. Smith R, Athanasou NA, Ostlere SJ, Vipond SE. Pregnancyassociated osteoporosis. QJM 1995;88:865-78
47. Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 1993;39:487-90
48. Cunningham GF. Screening for osteoporosis. N Engl J Med 2005;353:1975; author reply
49. Carbone LD, Palmieri GM, Graves SC, Smull K. Osteoporosis of pregnancy: Long-Term follow-up of patients and their offspring. Obstet Gynecol 1995;86:664-6
50. Melton 3rd LJ, Bryant SC, Wahner HW, et al. Influence of breastfeeding and other reproductive factors on bone mass later in life. Osteoporos Int 1993;3:76-83
51. Sowers M, Crutchfield M, Jannausch M, et al. A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 1991;77:841-5
52. Zeghoud F, Vervel C, Guillozo H, et al. Subclinical vitamin D deficiency in neonates: Definition and response to vitamin D supplements. Am J Clin Nutr 1997;65:771-8
53. Javaid MK, Crozier SR, Harvey NC, et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: A longitudinal study. Lancet 2006;367:36-43
54. Bodnar LM, Simhan HN, Powers RW, et al. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007;137:447-52
55. Baker AM, Haeri S, Camargo Jr. CA, et al. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab 2010;95:5105-9
56. Bodnar LM, Catov JM, Simhan HN, et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007;92:3517-22
57. Powe CE, Seely EW, Rana S, et al. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension 2010;56:758-63
58. Trumbo PR, Ellwood KC. Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension: Preeclampsia: An evidence-based review by the US Food and Drug Administration. Nutr Rev 2007;65:78-87
59. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010;8:CD001059. DOI: 10.1002/14651858.CD001059.pub3
60. Imdad A, Jabeen A, Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: A meta-Analysis of studies from developing countries. BMC Public Health 2011;11:S18
61. Bodnar LM, Catov JM, Zmuda JM, et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr 2010;140:999-1006
62. Leffelaar ER, Vrijkotte TG, van Eijsden M. Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: Results of the multi-ethnic Amsterdam Born Children and their Development cohort. Br J Nutr 2010;104:108-17
63. Morley R, Carlin JB, Pasco JA, Wark JD. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab 2006;91:906-12
64. Thorne-Lyman A, Fawzi WW. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: A systematic review and meta-Analysis. Paediatr Perinat Epidemiol 2012;26:75-90
65. Zhang C, Qiu C, Hu FB, et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One 2008;3:e3753